Metabolic and Molecular Imaging of the Diabetic Cardiomyopathy
- 20 May 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 126 (11), 1628-1645
- https://doi.org/10.1161/CIRCRESAHA.120.315899
Abstract
The term diabetic cardiomyopathy is defined as the presence of abnormalities in myocardial structure and function that occur in the absence of, or in addition to, well-established cardiovascular risk factors. A key contributor to this abnormal structural-functional relation is the complex interplay of myocardial metabolic remodeling, defined as the loss the flexibility in myocardial substrate metabolism and its downstream detrimental effects, such as mitochondrial dysfunction, inflammation, and fibrosis. In parallel with the growth in understanding of these biological underpinnings has been developmental advances in imaging tools such as positron emission tomography and magnetic resonance imaging and spectroscopy that permit the detection and in many cases quantification, of the processes that typifies the myocardial metabolic remodeling in diabetic cardiomyopathy. The imaging readouts can be obtained in both preclinical models of diabetes mellitus and patients with diabetes mellitus facilitating the bi-directional movement of information between bench and bedside. Moreover, imaging biomarkers provided by these tools are now being used to enhance discovery and development of therapies designed to reduce the myocardial effects of diabetes mellitus through metabolic modulation. In this review, the use of these imaging tools in the patient with diabetes mellitus from a mechanistic, therapeutic effect, and clinical management perspective will be discussed.This publication has 141 references indexed in Scilit:
- Sex and Type 2 Diabetes: Obesity‐Independent Effects on Left Ventricular Substrate Metabolism and Relaxation in HumansObesity, 2012
- Measuring intracellular pH in the heart using hyperpolarized carbon dioxide and bicarbonate: a 13C and 31P magnetic resonance spectroscopy studyCardiovascular Research, 2009
- In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in RodentsCirculation: Cardiovascular Imaging, 2009
- Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPHAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feedingCardiovascular Research, 2009
- Multimodality Cardiovascular Molecular Imaging, Part IICirculation: Cardiovascular Imaging, 2009
- PET detection of the impact of dobutamine on myocardial glucose metabolism in women with type 1 diabetes mellitusJournal of Nuclear Cardiology, 2008
- Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathyJournal of Cellular and Molecular Medicine, 2008
- In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonanceProceedings of the National Academy of Sciences of the United States of America, 2008
- Association Between Diabetes Mellitus and Left Ventricular Hypertrophy in a Multiethnic PopulationThe American Journal of Cardiology, 2008